UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

Value in health, 2012-11, Vol.15 (7), p.A352-A352

2012

Volltextzugriff (PDF)

The cost-effectiveness of routine childhood varicella vaccination in Germany

Vaccine, 2003-03, Vol.21 (11), p.1256-1267

2003

Volltextzugriff (PDF)

Empirical data on the varicella situation in Germany for vaccination decisions

Clinical microbiology and infection, 2004-05, Vol.10 (5), p.425-430

2004

Volltextzugriff (PDF)

PUK11 Preliminary Cost-Minimization Analysis of Continuous Versus Intermittent Renal Replacement Therapy in Intensive Care Patients Experiencing Acute Renal Failure

Value in health, 2011, Vol.14 (7), p.A332-A332

2011

Volltextzugriff (PDF)

PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain

Value in health, 2011, Vol.14 (7), p.A248-A249

2011

Volltextzugriff (PDF)

Cardiac Resynchronization Therapy (CRT) in Heart Failure—A Model to Assess the Economic Value of this New Medical Technology

Value in health, 2005-03, Vol.8 (2), p.128-139

Banz, Kurt

2005

Volltextzugriff (PDF)

PHP199 - Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceuticals

Value in health, 2014-11, Vol.17 (7), p.A437-A437

2014

Volltextzugriff (PDF)

Ökonomische Analysen in der Interventionellen Radiologie

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2002, Vol.174 (2), p.149-159

2002

Volltextzugriff (PDF)

Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion

PharmacoEconomics, 2002, Vol.20 (3), p.203-213

2002

Volltextzugriff (PDF)

Cost-effectiveness analysis of treatment of renal-artery stenoses by medication, angioplasty, stenting and surgery

Minimally invasive therapy and allied technologies, 2001, Vol.10 (1), p.55-65

2001

Volltextzugriff (PDF)

PCN46 COST SAVINGS RELATED TO SUPERIOR ADVERSE EVENT PROFILE OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE IN THE FIRST-LINE THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY: A SENSITIVITY ANALYSIS ON THE ECOG STATUS

Value in health, 2009, Vol.12 (7), p.A265-A265

2009

Volltextzugriff (PDF)

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN SPAIN

Value in health, 2009, Vol.12 (7), p.A264-A264

2009

Volltextzugriff (PDF)

PCN47 COSTS OF TREATING SEVERE ADVERSE EVENTS OBSERVED WITH A REGIMEN OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE IN THE FIRST-LINE THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY

Value in health, 2009, Vol.12 (7), p.A265-A265

2009

Volltextzugriff (PDF)

Validation of Health Economic Models: The Example of EVITA

Value in health, 2003-09, Vol.6 (5), p.551-559

2003

Volltextzugriff (PDF)

PCV86 COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN HIGH-RISK PATIENTS WITH SYMPTOMATIC AORTIC VALVE STENOSIS IN FRANCE

Value in health, 2009, Vol.12 (7), p.A328-A328

2009

Volltextzugriff (PDF)

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany

Medical microbiology and immunology, 2002-10, Vol.191 (2), p.89-96

2002

Volltextzugriff (PDF)

PIN2 A COST-BENEFIT ANALYSIS OF DIFFERENT VARICELLA VACCINATION STRATEGIES INVOLVING ITALIAN CHILDREN AND ADOLESCENTS

Value in health, 2006-11, Vol.9 (6), p.A299-A299

2006

Volltextzugriff (PDF)

PEE9: THE SOCIETAL COST OF ATOPIC DERMATITIS IN GERMANY

Value in health, 2001-09, Vol.4 (6), p.516-516

2001

Volltextzugriff (PDF)

Economic evaluation of varicella vaccination programmes: a review of the literature

PharmacoEconomics, 2004-01, Vol.22 (2), p.133-138

2004

Volltextzugriff (PDF)

PIN21 BUDGET IMPACT ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN GERMANY

Value in health, 2003-11, Vol.6 (6), p.753-753

2003

Volltextzugriff (PDF)

IR8: COST-EFFECTIVENESS OF COMBINED HEPATITIS A AND B VACCINATION AND HEPATITIS B MONOVACCINATION IN SWITZERLAND AND AUSTRIA

Value in health, 1999-09, Vol.2 (5), p.359-359

1999

Volltextzugriff (PDF)

Evaluation of the potential clinical and economic effects of bodyweight stabilisation with acarbose in patients with type 2 diabetes mellitus. A decision-analytical approach

PharmacoEconomics, 1998-04, Vol.13 (4), p.449-459

1998

Volltextzugriff (PDF)

Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan

The Journal of invasive cardiology, 2000-04, Vol.12 (4), p.194

2000

Volltextzugriff (PDF)

PIN35 VARICELLA VACCINATION OF PRE-SCHOOL CHILDREN: DETERMINING OPTIMAL COVERAGE LEVELS

Value in health, 2002-11, Vol.5 (6), p.575-576

2002

Volltextzugriff (PDF)

PIN18 RELEVANCE OF COMPLICATIONS AS COST DRIVERS OF VARICELLA

Value in health, 2002-11, Vol.5 (6), p.568-568

2002

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(100)
Deutsch
(33)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

The cost-effectiveness of routine childhood varicella vaccination in Germany

Empirical data on the varicella situation in Germany for vaccination decisions

PUK11 Preliminary Cost-Minimization Analysis of Continuous Versus Intermittent Renal Replacement Therapy in Intensive Care Patients Experiencing Acute Renal Failure

PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain

Cardiac Resynchronization Therapy (CRT) in Heart Failure—A Model to Assess the Economic Value of this New Medical Technology

PHP199 - Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceuticals

Ökonomische Analysen in der Interventionellen Radiologie

Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion

Cost-effectiveness analysis of treatment of renal-artery stenoses by medication, angioplasty, stenting and surgery

PCN46 COST SAVINGS RELATED TO SUPERIOR ADVERSE EVENT PROFILE OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE IN THE FIRST-LINE THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY: A SENSITIVITY ANALYSIS ON THE ECOG STATUS

PCN44 TREATMENT COSTS OF GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN SPAIN

PCN47 COSTS OF TREATING SEVERE ADVERSE EVENTS OBSERVED WITH A REGIMEN OF BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE IN THE FIRST-LINE THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY

Validation of Health Economic Models: The Example of EVITA

PCV86 COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN HIGH-RISK PATIENTS WITH SYMPTOMATIC AORTIC VALVE STENOSIS IN FRANCE

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany

PIN2 A COST-BENEFIT ANALYSIS OF DIFFERENT VARICELLA VACCINATION STRATEGIES INVOLVING ITALIAN CHILDREN AND ADOLESCENTS

PEE9: THE SOCIETAL COST OF ATOPIC DERMATITIS IN GERMANY

Economic evaluation of varicella vaccination programmes: a review of the literature

PIN21 BUDGET IMPACT ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN GERMANY

IR8: COST-EFFECTIVENESS OF COMBINED HEPATITIS A AND B VACCINATION AND HEPATITIS B MONOVACCINATION IN SWITZERLAND AND AUSTRIA

Evaluation of the potential clinical and economic effects of bodyweight stabilisation with acarbose in patients with type 2 diabetes mellitus. A decision-analytical approach

Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan

PIN35 VARICELLA VACCINATION OF PRE-SCHOOL CHILDREN: DETERMINING OPTIMAL COVERAGE LEVELS

PIN18 RELEVANCE OF COMPLICATIONS AS COST DRIVERS OF VARICELLA

Suchergebnisse filtern